TradeFlare's AI research teams analysed IMNM on 11 market nights between May 11, 2026 and September 8, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| September 8, 2026 | HOLD | $26.76 | — / — | -10.7% | -28.0% | The current market and stock-specific conditions do not present a clear, high-conviction trading opportunity. |
| August 26, 2026 | BUY | $29.39 | $34.07 / $24.98 | -4.9% | -22.3% | The stock is breaking out on good fundamentals and sentiment, suggesting a move that will play out over a few weeks. |
| August 13, 2026 | BUY | $27.99 | $32.19 / $23.79 | +6.3% | -6.6% | The 52-week breakout suggests immediate upside potential, but the high risk score warrants a shorter-term focus. |
| July 13, 2026 | BUY | $23.35 | — / — | -2.8% | +12.7% | Continued positive clinical trial data for varegacestat. |
| July 10, 2026 | BUY | $24.17 | — / — | -4.4% | +7.2% | The stock is currently in a neutral market environment, and the mixed team signals do not warrant a buy. |
| July 9, 2026 | BUY | $24.01 | $28.81 / $20.41 | -8.2% | +6.8% | The post-earnings drift signal suggests a short-term upward momentum. |
| June 10, 2026 | BUY | $18.39 | — / — | +2.0% | +28.6% | Positive Phase 3 data for varegacestat and NDA submission. |
| May 14, 2026 | BUY | $22.20 | — / — | +4.3% | -16.5% | NDA submission for Varegacestat represents a significant de-risking event and potential commercialization milestone. |
| May 13, 2026 | HOLD | $22.69 | — / — | -3.0% | -17.3% | NDA submission for Varegacesta represents a significant regulatory milestone. |
| May 12, 2026 | HOLD | $23.00 | — / — | -13.3% | -20.0% | Positive clinical trial data for oncology assets. |
| May 11, 2026 | BUY | $22.44 | $25.30 / $19.07 | -13.5% | -20.0% | The stock is currently consolidating, and a clear catalyst is needed to initiate a trade. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.